Results 151 to 160 of about 22,304 (253)

Contraceptives in chronic lymphocytic leukemia (CLL): a narrative review. [PDF]

Ann Hematol
Al-Shibly R, Qassim N, Alfarsi K, AlShemmari S, Yassin M.   +4 more
europepmc   +1 more source

Role of Levonorgestrel Intrauterine System (LNG-IUS) in the Management of Abnormal Uterine Bleeding (AUB): A Conservative Approach to Preserve the Uterus.

J Pharm Bioallied Sci
Naagar JK, Jaiswal R, Mishra N, Jain R.
europepmc   +1 more source

Uterine Serous Carcinoma Following the Insertion of Levonorgestrel Intrauterine System: A Case Report and Literature Review. [PDF]

Int J Womens Health
Hu Q, Yao Y, Xie X, Zhong X, Luo Y, Huang X.   +5 more
europepmc   +1 more source

Hysteroscopic sutureless fixation of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. [PDF]

Front Med (Lausanne)
Shen L, Zhang J, Wu J, Ye M, Shao H, Zhang F.   +5 more
europepmc   +1 more source

Effects of Methanol Leaf Extract of Datura stramonium on Some Liver Biomarkers of Levonorgestrel-Induced Albino Rats

Amen Ananias, Dawoye Yusufu, Gaddafi Suleiman, Israel Ahmadu Kiledu   +3 more
openalex   +2 more sources

Silent Migration of an Intrauterine Device into the Peritoneum: A Case Report. [PDF]

Cureus
Simwa MA, Karwal S, Ibrahim S, Dave A, Alsobhi A, Mensah E, Hani M.   +6 more
europepmc   +1 more source

POLE-mutated atypical endometrial hyperplasia in an adolescent: a 5-year follow-up with LNG-IUS-a case report and literature review. [PDF]

BMC Womens Health
Liu J, Han Y, Wu S.
europepmc   +1 more source

Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device-Results From the feMMe Phase 2 Randomized Clinical Trial. [PDF]

Am J Surg Pathol
Baxter E, Robledo KP, Cummings M, Alizart M, Smith D, Obermair A.   +5 more
europepmc   +1 more source

O uso indiscriminado do levonorgestrel como contraceptivo de

Jennifer Firmino da Silva, Melissa Cardoso Deuner   +1 more
openalex   +2 more sources

Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal Women.

JAMA Oncol
Hadizadeh F, Koteci A, Karlsson T, Ek WE, Johansson Å.   +4 more
europepmc   +1 more source